JOHANNESBURG: Namibia has stopped the use of Sputnik V Covid-19 Russia after worries submitted by neighboring South Africa, the Ministry of Health said on Saturday.
The South African neighboring country earlier this week said it would not approve Sputnik V because of the concern it could increase the risk of HIV infection among men, the claims of the vaccine developer was unfounded.
The Namibian Ministry of Health said in a statement that following the South African decision to suspend, with direct effects, the use of shots to formulas was listed for emergency use by the World Health Organization.
“The reason for termination of vaccine administration is being carried out because of the caution that men who receive sputnik v can be at higher risk of HIV when exposed,” service said.
Namibia has received the delivery of Serbian contributions from 30,000 sputnik doses – including less than 120 has been given this far.
The South African health product regulator on Monday said it would not ratify the use of sputnik based on previous research testing the security of modified adenovirus forms – this type of virus that caused respiratory tract infections – known as AD5 and contained in Jab.
Regulators said two previous studies, one in South Africa and one in America, found the risk of increased HIV infection among men who were linked to the AD5-vector vaccine.
In the two experiments, “Ad5-vector vaccine administration is associated with an increase in HIV vulnerability / acquisition in men”, said the regulator last week.
The Russian Gamaleaaya Center, which developed Sputnik V, said all the allegations of the relationship between vaccines and HIV were unfounded.
It was said that clinical studies of more than 7,000 participants showed “there was no significantly significant increase in HIV-1 infection among Adenovirus type-5 vector vaccine receivers.”